Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study
- Nieves Martinez Chanza
- , Wanling Xie
- , Mehmet A. Bilen
- , Hannah Dzimitrowicz
- , Jarred Burkart
- , Daniel Geynisman
- , Archana Balakrishnan
- , I. Alex Bowman
- , Rohit K. Jain
- , Walter M. Stadler
- , Yousef Zakharia
- , Vivek Narayan
- , Benoit Beuselinck
- , Rana R. McKay
- , Abhishek Tripathi
- , Russell Pachynski
- , Andrew W. Hahn
- , Jo Ann Hsu
- , Sumit A. Shah
- , Elaine T. Lam
- Harvard University
- Emory University
- Duke University
- Ohio State University
- Wayne State University
- University of Texas Southwestern Medical Center
- University of South Florida
- Roswell Park Cancer Institute
- Kite, a Gilead Company
- University of Chicago
- University of Iowa
- University of Pennsylvania
- KU Leuven
- University of California at San Diego
- University of Oklahoma
- Stephenson Cancer Center
- Washington University St. Louis
- University of Utah
- City of Hope National Medical Center
- Stanford University
- University of Colorado
- University of Colorado Boulder
- University of Colorado Cancer Center
- University of Colorado Anschutz Medical Campus
- Dana-Farber Cancer Institute
- Dana-Farber/Harvard Cancer Center
Research output: Contribution to journal › Article › peer-review
144
Scopus
citations